Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
In this update we added new monographs for CEFEPIME HYDROCHLORIDE AND ENMETAZOBACTAM, CEFTOBIPROLE MEDOCARIL SODIUM, and DESMOPRESSIN ACETATE.
We also added new stability information to the monographs for CEFTAZIDIME AND AVIBACTAM SODIUM, CETUXIMAB, DECITABINE, DEXAMETHASONE SODIUM PHOSPHATE, INSULIN ASPART, METHOCARBAMOL, MOXIFLOXACIN HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, and PANITUMUMAB.
Compatibility information was added for these drugs: ACETAMINOPHEN, ALPROSTADIL, AMIKACIN SULFATE, AMOXACILLIN SODIUM, CEFOTAXIME SODIUM, CLONIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DROPERIDOL, GENTAMICIN SULFATE, GRANISETRON HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, MORPHINE HYDROCHLORIDE, MORPHINE SULFATE, OXYCODONE HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, SUFENTANIL CITRATE, TOBRAMYCIN SULFATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.